Apollon Acquires Intellectual Property from Aion
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
Apollon Formularies plc Announces Grand Opening of International Cancer Institute
Grand Opening of International Cancer and Chronic Pain Institute LONDON, UK / ACCESSWIRE / February 3, 2022 / Apollon Formularies plc (AQSE:APOL), ("Apollon" or the "Company"), a UK based international...
Apollon Formularies plc Announces CEO Review of 2021
LONDON, UK / ACCESSWIRE / January 25, 2022 / Apollon Formularies plc (AQSE:APOL)("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and trading...